Influence of ethnicity on response to asthma drugs

Bibliography

• Oxford Dictionaries. Oxford University Press. Retrieved 28 December 2014
   Google Scholar
• Abramson HJ. Ethnic diversity in catholic America. Wiley; New York, NY: 1973
   Google Scholar
• Davidson E, Liu JJ, Sheikh A. The impact of ethnicity on asthma care. Prim Care Respir J 2010;19:202–8
   PubMedGoogle Scholar
• Cabana MD, Lara M, Shannon J. Racial and ethnic disparities in the quality of asthma care. Chest 2007;132(5 Suppl):810S–7S
   PubMed Web of Science ®Google Scholar
• Lakhanpaul M, Bird D, Manikam L, et al. A systematic review of explanatory factors of barriers and facilitators to improving asthma management in South Asian children. BMC Public Healt 2014;14:403
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Castro M, Lehman E, et al. Impact of race on asthma treatment failures in the Asthma Clinical Research Network. Am J Respir Crit Care Med 2011;184:1247–53
   PubMed Web of Science ®Google Scholar
• Cantarero-Arévalo L, Ersbøll AK, Holstein BE, et al. Ethnic and migrant differences in the use of anti-asthmatic medication for children: the effect of place of residence. Pharmacoepidemiol Drug Saf 2014;23:95–104
   PubMed Web of Science ®Google Scholar
• Ortega VE, Meyers DA. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol 2014;133:16–26
   PubMed Web of Science ®Google Scholar
• Xie HG, Kim RB, Wood AJ, Stein CM. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol 2001;41:815–50
   PubMed Web of Science ®Google Scholar
• Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacol Rev 2012;64:450–504
   PubMed Web of Science ®Google Scholar
• Chung LP, Waterer G, Thompson PJ. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma. Clin Exp Allergy 2011;41:312–26
   PubMed Web of Science ®Google Scholar
• Lima JJ. Do genetic polymorphisms alter patient response to inhaled bronchodilators? Expert Opin Drug Metab Toxicol 2014;10:1231–40
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Kunselman SJ, Chinchilli VM, et al. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009;374:1754–64
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Nelson HS, Kraft M, et al. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med 2010;181:676–87
   PubMed Web of Science ®Google Scholar
• Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505–12
   PubMed Web of Science ®Google Scholar
• Maxwell TJ, Ameyaw MM, Pritchard S, et al. Beta-2 adrenergic receptor genotypes and haplotypes in different ethnic groups. Int J Mol Med 2005;16:573–80
   PubMed Web of Science ®Google Scholar
• Burchard EG, Avila PC, Nazario S, et al. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med 2004;169:386–92
   PubMed Web of Science ®Google Scholar
• Naqvi M, Thyne S, Choudhry S, et al. Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma. J Asthma 2007;44:639–48
   PubMed Web of Science ®Google Scholar
• Choudhry S, Ung N, Avila PC, et al. Pharmacogenetic differences in response to albuterol between Puerto Rican and Mexican asthmatics. Am J Respir Crit Care Med 2005;171:563–70
   PubMed Web of Science ®Google Scholar
• Weir TD, Mallek N, Sandford AJ, et al. β2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998;158:787–91
   PubMed Web of Science ®Google Scholar
• Basu K, Palmer CN, Tavendale R, et al. Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. J Allergy Clin Immunol 2009;124:1188–94
   PubMed Web of Science ®Google Scholar
• Ortega VE. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. Clin Genet 2014;86:12–20
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Kunselman SJ, Chinchilli VM, et al. Effect of β2-adrenergic receptor polymorphism on response to long acting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009;374:1754–64
   PubMed Web of Science ®Google Scholar
• Ortega VE, Hawkins GA, Moore WC, et al. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med 2014;2:204–13
   PubMed Web of Science ®Google Scholar
• Drake KA, Torgerson DG, Gignoux CR, et al. A genome-wide association study of bronchodilator response in Latinos implicates rare variants. J Allergy Clin Immunol 2014;133:370–8
   PubMed Web of Science ®Google Scholar
• Himes BE, Jiang X, Hu R, et al. Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene. PLoS Genet 2012;8:e1002824
   PubMed Web of Science ®Google Scholar
• Kim SH, Ye YM, Lee HY, et al. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy. J Clin Pharm Ther 2011;36:399–405
   PubMed Web of Science ®Google Scholar
• Rogers AJ, Tantisira KG, Fuhlbrigge AL, et al. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics 2009;10:1231–42
   PubMed Web of Science ®Google Scholar
• Chan MT, Leung DY, Szefler SJ, Spahn JD. Patients suffering from steroid-insensitive asthma are more likely to be African-American compared with those with steroid-sensitive asthma. J Allergy Clin Immunol 1998;101:594–601
   PubMed Web of Science ®Google Scholar
• Federico MJ, Covar RA, Brown EE, et al. Racial differences in T-lymphocyte response to glucocorticoids. Chest 2005;127:571–8
   PubMed Web of Science ®Google Scholar
• Maranville JC, Baxter SS, Torres JM, Di Rienzo A. Inter-ethnic differences in lymphocyte sensitivity to glucocorticoids reflect variation in transcriptional response. Pharmacogenomics J 2013;13:121–9
   PubMed Web of Science ®Google Scholar
• Rosenwasser L, Klemm JD, Klemm DJ, et al. Association of asthmatic steroid insensitivity with an IL-4 gene promoter polymorphism [abstract 771]. J Allergy Clin Immunol 2001;107:S235
   PubMed Web of Science ®Google Scholar
• Burchard EG, Silverman EK, Rosenwasser LJ, et al. Association between a sequence variant in the IL-4 gene promoter and FEV1 in asthma. Am J Respir Crit Care Med 1999;160:919–22
   PubMed Web of Science ®Google Scholar
• Gould W, Peterson EL, Karungi G, et al. Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma. J Allergy Clin Immunol 2010;126:1131–8
   PubMed Web of Science ®Google Scholar
• Blake K, Cury JD, Hossain J, et al. Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16. Pulm Pharmacol Ther 2013;26:342–7
   PubMed Web of Science ®Google Scholar
• Qiu Y, Zhang D, Qin Y, Yin KS. Effect of β2-adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients. Multidiscip Respir Med 2014;9:22
   Google Scholar
• Tantisira KG, Lasky-Su J, Harada M, et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 2011;365:1173–83
   PubMed Web of Science ®Google Scholar
• Lima JJ, Zhang S, Grant A, et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 2006;173:379–85
   PubMed Web of Science ®Google Scholar
• Weiss ST, Litonjua AA, Lange C, et al. Overview of the pharmacogenetics of asthma treatment. Pharmacogenomics J 2006;6:311–26
   PubMed Web of Science ®Google Scholar
• Tcheurekdjian H, Via M, De Giacomo A, et al. ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos. J Allergy Clin Immunol 2010;126:853–8
   PubMed Web of Science ®Google Scholar
• Mougey E, Lang JE, Allayee H, et al. ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma. Clin Exp Allergy 2013;43:512–20
   PubMed Web of Science ®Google Scholar
• Obase Y, Shimoda T, Kawano T, et al. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 2003;73:468–74
   PubMed Web of Science ®Google Scholar
• Klein K, Winter S, Turpeinen M, et al. Pathway-targeted pharmacogenomics of CYP1A2 in human liver. Front Pharmacol 2010;1:129
   PubMed Web of Science ®Google Scholar
• Galetin A, Brown C, Hallifax D, et al. Utility of recombinant enzyme kinetics in prediction of human clearance: impact of variability, CYP3A5, and CYP2C19 on CYP3A4 probe substrates. Drug Metab Dispos 2004;32:1411–20
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Chinchilli V, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukoriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783–90
   PubMed Web of Science ®Google Scholar
• Bossley CJ, Saglani S, Kavanagh C, et al. Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur Respir J 2009;34:1052–9
   PubMed Web of Science ®Google Scholar
• Stapleton M, Howard-Thompson A, George C, et al. Smoking and asthma. J Am Board Fam Med 2011;24:313–22
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010;120:76–85
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, Woltmann G, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875–9
   PubMed Web of Science ®Google Scholar
• Zahran HS, Bailey C. Factors associated with asthma prevalence among racial and ethnic groups - United States, 2009–2010 Behavioral Risk Factor Surveillance System. J Asthma 2013;50:583–9
   PubMed Web of Science ®Google Scholar
• Chan MT, Leung DY, Szefler SJ, Spahn JD. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 1998;101:594–601
   PubMed Web of Science ®Google Scholar
• Naqvi M, Tcheurekdjian H, DeBoard JA, et al. Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients. Ann Allergy Asthma Immunol 2008;100:551–7
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen C, Niu T, et al. Association of asthma with beta2-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001;163:1404–9
   PubMed Web of Science ®Google Scholar
• Cazzola M, Segreti A, Calzetta L, Rogliani P. Comorbidities of asthma: current knowledge and future research needs. Curr Opin Pulm Med 2013;19:36–41
   PubMed Web of Science ®Google Scholar
• Cazzola M, Calzetta L, Bettoncelli G, et al. Asthma and comorbid medical illness. Eur Respir J 2011;38:42–9
   PubMed Web of Science ®Google Scholar
• Kim S, Camargo CAJr. Sex-race differences in the relationship between obesity and asthma: the behavioral risk factor surveillance system, 2000. Ann Epidemiol 2003;13:666–73
   PubMed Web of Science ®Google Scholar
• Bender BG, Fuhlbrigge A, Walders N, Zhang L. Overweight, race, and psychological distress in children in the Childhood Asthma Management Program. Pediatrics 2007;120:805–13
   PubMed Web of Science ®Google Scholar
• Gergen PJ, Togias A. Inner city asthma. Immunol Allergy Clin North Am 2015;35:101–14
   PubMed Web of Science ®Google Scholar
• Borrell LN, Nguyen EA, Roth LA, et al. Childhood obesity and asthma control in the GALA II and SAGE II studies. Am J Respir Crit Care Med 2013;187:697–702
   PubMed Web of Science ®Google Scholar
• Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007;101:2240–7
   PubMed Web of Science ®Google Scholar
• Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495–503
   PubMed Web of Science ®Google Scholar
• Gowers AM, Cullinan P, Ayres JG, et al. Does outdoor air pollution induce new cases of asthma? Biological plausibility and evidence; a review. Respirology 2012;17:887–98
   PubMed Web of Science ®Google Scholar
• Nishimura KK, Galanter JM, Roth LA, et al. Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies. Am J Respir Crit Care Med 2013;188:309–18
   PubMed Web of Science ®Google Scholar
• Boehmer TK, Foster SL, Henry JR, et al. Residential proximity to major highways - United States, 2010. MMWR Surveill Summ 2013;62(Suppl 3):46–50
   PubMedGoogle Scholar
• Lewis TC, Robins TG, Dvonch JT, et al. Air pollution-associated changes in lung function among asthmatic children in Detroit. Environ Health Perspect 2005;113:1068–75
   PubMed Web of Science ®Google Scholar
• Hernández-Cadena L, Holguin F, Barraza-Villarreal A, et al. Increased levels of outdoor air pollutants are associated with reduced bronchodilation in children with asthma. Chest 2009;136:1529–36
   PubMed Web of Science ®Google Scholar
• Lewis TC, Robins TG, Mentz GB, et al. Air pollution and respiratory symptoms among children with asthma: vulnerability by corticosteroid use and residence area. Sci Total Environ 2013;448:48–55
   PubMed Web of Science ®Google Scholar
• Dima AL, Hernandez G, Cunillera O, et al. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J 2015;45(4):994–1018
   PubMed Web of Science ®Google Scholar
• Farber HJ, Capra AM, Finkelstein JA, et al. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma 2003;40:17–25
   PubMed Web of Science ®Google Scholar
• Williams LK, Joseph CL, Peterson EL, et al. Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids. J Allergy Clin Immunol 2007;119:168–75
   PubMed Web of Science ®Google Scholar
• Koster ES, Raaijmakers JA, Vijverberg SJ, Maitland-van der Zee AH. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study. Pharmacoepidemiol Drug Saf 2011;20:1064–72
   PubMed Web of Science ®Google Scholar
• Sheikh A, Halani L, Bhopal R, et al. Facilitating the recruitment of minority ethnic people into research: qualitative case study of South Asians and asthma. PLoS Med 2009;6:e1000148
   PubMed Web of Science ®Google Scholar
• Sheikh A, Netuveli G, Kai J, Panesar SS. Comparison of reporting of ethnicity in US and European randomised controlled trials. BMJ 2004;329:87–8
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research – amended. Available from: http://grants.nih.gov/grants/funding/wom en_min/guidelines_amended_10_2001.htm [Last Accessed 29 December 2014]
   Google Scholar
• Chung KF. New treatments for severe treatment-resistant asthma: targeting the right patient. Lancet Respir Med 2013;1:639–52
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Castro M, Lehman E, et al. Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med 2011;184:1247–53
   PubMed Web of Science ®Google Scholar
• Chang TS, Lemanske RFJr, Mauger DT, et al. Childhood asthma clusters and response to therapy in clinical trials. J Allergy Clin Immunol 2014;133:363–9
   PubMed Web of Science ®Google Scholar
• Park HW, Tantisira KG, Weiss ST. Pharmacogenomics in asthma therapy: where are we and where do we go? Annu Rev Pharmacol Toxicol 2015;55:129–47
   PubMed Web of Science ®Google Scholar
• Meyers DA, Bleecker ER, Holloway JW, Holgate ST. Asthma genetics and personalised medicine. Lancet Respir Med 2014;2:405–15
   PubMed Web of Science ®Google Scholar